Sign in

CIK 0001819790

  • Large accelerated filer

Tarsus Pharmaceuticals, Inc.

Sign in to watch
Ticker
TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
814717861
Phone
+1 949-409-9820
Business address
15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
  1. 4 Open-market sale President/CEO and Board Chair sold 10,415 shares at $30.60 ($318,699)
  2. 4 Open-market sale Chief Human Resources Officer sold 4,314 shares at $30.60 ($132,008)
  3. 4 Open-market sale Chief Operating Officer sold 4,879 shares at $30.60 ($149,297)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $20.22 ($161,760)
  12. 4 Planned sale CHIEF MEDICAL OFFICER sold 2,252 shares at $20.00 ($45,040)
  13. 4 Planned sale President/CEO and Board Chair sold 40,000 shares at an average $20.27 ($810,623)
  14. 4 Open-market buy Director bought 1,000 shares at $18.96 ($18,960)
  15. 4 Option exercise Director acquired 5,000 shares (option exercise)
  16. 4 Open-market sale Chief Human Resources Officer sold 8,355 shares at $16.31 ($136,270)
  17. 4 Open-market sale General Counsel sold 8,356 shares at $16.31 ($136,286)
  18. 4 Planned sale President/CEO and Board Chair sold 8,000 shares at an average $18.37 ($146,933)
  19. 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $13.24 ($105,920)
  20. 4 Planned sale CHIEF MEDICAL OFFICER sold 1,604 shares at $18.00 ($28,872)

Page 7 of 17 · 330 filings